| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 0,220 | 0,249 | 27.02. |
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Do | Circio Holding ASA: Correction - Mandatory notification of trade by primary insider related to the rights issue | 11 | Oslo Børs | ||
| 19.02. | Circio Holding ASA: Circio invites to R&D and corporate update webcast on 26 February 2026 | 1 | Oslo Børs | ||
| 17.02. | Circio Holding ASA: Registration of share capital increase following directed issue of NOK 3.6 million | - | Oslo Børs | ||
| 16.02. | CIRCIO HOLDING ASA: INFORMATION ABOUT WARRANTS AND COMMENCEMENT OF TRADING | 1 | Oslo Børs | ||
| CIRCIO Aktie jetzt für 0€ handeln | |||||
| 14.02. | Circio Holding ASA: Circio announces allocation of stock options to key employees | - | Oslo Børs | ||
| 12.02. | Circio Holding ASA: Registration of share capital increase following rights issue and private placement | 1 | Oslo Børs | ||
| 06.02. | Circio Holding ASA completes directed issue of NOK 3.6 million | 1 | Oslo Børs | ||
| 30.01. | Circio Holding ASA Mandatory notification of trade by primary insiders and close associates related to the rights issue and private placement | - | Oslo Børs | ||
| 30.01. | Circio Holding ASA Final results of the oversubscribed rights issue | 2 | Oslo Børs | ||
| 29.01. | Circio Holding ASA Subscription period for the rights issue expires today | 1 | Oslo Børs | ||
| 28.01. | Circio Holding ASA Exercise of subscription rights in the rights issue by primary insiders | - | Oslo Børs | ||
| 23.01. | Circio Holding ASA Last day of trading in subscription rights in the rights issue | 2 | Oslo Børs | ||
| 16.01. | Circio Holding ASA Exercise of subscription rights in the rights issue by primary insiders | 2 | Oslo Børs | ||
| 15.01. | Circio Holding ASA Receipt of subscription rights in the rights issue by primary insiders and their close associates | 1 | Oslo Børs | ||
| 15.01. | Circio Holding ASA Commencement of the subscription period for the rights issue | 2 | Oslo Børs | ||
| 13.01. | Circio Holding ASA Approval and publication of prospectus for the rights issue | 2 | Oslo Børs | ||
| 13.01. | Circio Holding ASA Ex. subscription rights today | 1 | Oslo Børs | ||
| 12.01. | Circio Holding ASA: Circio invites to live webcast on 15 January 2026 to provide information about the upcoming rights issue | 1 | Oslo Børs | ||
| 12.01. | Circio Holding ASA Extraordinary general meeting held, all agenda items approved | 1 | Oslo Børs | ||
| 12.01. | XFRA CAPITAL ADJUSTMENT INFORMATION - 12.01.2026 | 790 | Xetra Newsboard | Das Instrument PGH DE000A1MMEV4 THE PAYM.GR.HLDG KG NA ON EQUITY wird cum Kapitalmassnahme gehandelt am 12.01.2026 und ex Kapitalmassnahme am 13.01.2026 The instrument PGH DE000A1MMEV4 THE PAYM.GR.HLDG... ► Artikel lesen |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| EVOTEC | 5,880 | +0,38 % | Evotec Aktie: Kann man "diesem Braten wirklich trauen"? | © Foto: Julia Koblitz auf Unsplash (Symbolbild)Neue Aufträge, ein Sparprogramm und frische Analystenkommentare. Die Evotec-Aktie sendet wieder Lebenszeichen. Doch wer die Geschichte dieses Hamburger... ► Artikel lesen | |
| MEDIGENE | 0,046 | +14,00 % | Medigene: Zurückziehung - 18.11.2025 | ||
| PAION | 0,090 | 0,00 % | PAION AG - Schwächesignale im Fokus | ||
| VALNEVA | 4,700 | -0,63 % | BioNTech, Valneva oder BB Biotech: Warum es HIER in Kürze knallt! | Die Biotechbranche steht zu Beginn des Jahres 2026 erneut im Spannungsfeld zwischen wissenschaftlicher Innovation und wachsender Skepsis der Kapitalmärkte. Nach Jahren extremer Kursbewegungen prüfen... ► Artikel lesen | |
| NOVAVAX | 8,495 | -0,97 % | FOMO an der Wall Street: Novavax meldet überraschenden Gewinn - Aktie schießt zweistellig hoch | © Foto: picture alliance / Ulrich Baumgarten | Ulrich BaumgartenEin Ergebnis, das niemand erwartet hatte, gepaart mit neuen Big-Pharma-Deals: Novavax sorgt für FOMO an der Wall Street. Wie lange hält... ► Artikel lesen | |
| INOVIO PHARMACEUTICALS | 1,500 | -2,60 % | Is Inovio Pharmaceuticals Stock Going to $0? | ||
| INFLARX | 0,774 | -0,71 % | Weekly Buzz: ARS Pharma's Neffy Goes East, SLS Advances, A Signal Of Hope For IFRX? | LONDON (dpa-AFX) - Despite the typical year-end slowdown, the week saw a steady stream of high-impact news, highlighted by global approvals, clinical trial readouts, new product launches, and... ► Artikel lesen | |
| BAVARIAN NORDIC | 26,360 | +0,15 % | Bavarian Nordic A/S: Bavarian Nordic Receives USD 22.5 Million Contract for its Mpox and Smallpox Vaccine from the Government of Canada | COPENHAGEN, Denmark, February 18, 2026 - Bavarian Nordic A/S (OMX: BAVA) today announced a new order valued at USD 22.5 million from the Public Health Agency of Canada (PHAC) for the Company's mpox... ► Artikel lesen | |
| VAXART | 0,630 | 0,00 % | Vaxart, Inc.: Vaxart Provides Business Update and Reports Third Quarter 2025 Financial Results | Entered into an exclusive license agreement with Dynavax for the Company's COVID-19 oral pill vaccine candidate for potential cumulative proceeds of up to $700 million plus royalties Completed enrollment... ► Artikel lesen | |
| REDHILL BIOPHARMA | 0,980 | +1,96 % | RedHill Biopharma Ltd. - 6-K, Report of foreign issuer | ||
| EMERGENT BIOSOLUTIONS | 6,850 | -0,52 % | Morning Market Movers: Neurogene, Duolingo, Xponential Fitness, Emergent BioSolutions See Big Swings | WASHINGTON (dpa-AFX) - At 6:22 a.m. ET on Friday, premarket trading is seeing notable activity in several stocks, with early price movements signaling potential opportunities before the opening... ► Artikel lesen | |
| TELIX PHARMACEUTICALS | 6,430 | +5,83 % | Telix Pharmaceuticals Limited: Telix Joins Forces with University Hospital Essen on PROMISE-PET: Optimizing Patient Management through AI-enabled PSMA-PET Imaging | ||
| SINOVAC BIOTECH | - | - | Sinovac Biotech Ltd. Announces Receipt of Nasdaq Notice of Delisting and Intention to Appeal | BEIJING--(BUSINESS WIRE)--Sinovac Biotech Ltd. (Nasdaq: SVA) ("SINOVAC" or the "Company"), a leading provider of biopharmaceutical products in China, announced today that on November 12, 2025, it received... ► Artikel lesen | |
| CYTOMX THERAPEUTICS | 4,570 | +0,84 % | SD-Tipp CytomX: Was tun nach +1.438% in 10 Monaten? | Unsere Aktien-Empfehlung CytomX Therapeutics erlebt derzeit einen außergewöhnlich starken Kursverlauf. Innerhalb kurzer Zeit hat sich das Papier von einem lange übersehenen Small-Cap-Titel zu einem... ► Artikel lesen | |
| AGENUS | 2,780 | -1,42 % | Agenus Inc.: Agenus meldet Abschluss einer strategischen Kooperationsvereinbarung mit Zydus Lifesciences im Wert von 141 Millionen US-Dollar zur Weiterentwicklung von BOT+BAL und Stärkung der Produktionskapazitäten in den USA | Agenus Inc. (Nasdaq: AGEN), ein führendes Unternehmen auf dem Gebiet der Immunonkologie, gab heute den Abschluss seiner bereits angekündigten strategischen Zusammenarbeit mit Zydus Lifesciences... ► Artikel lesen |